Video Upload Options

References

1. Bartsch O, Rasi S, Delicado A, Dyack S, Neumann LM, Seemanová E, Volleth M,Haaf T, Kalscheuer VM. Evidence for a new contiguous gene syndrome, thechromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome. Hum Genet. 2006 Sep;120(2):179-86.
2. Brisset S, Joly G, Ozilou C, Lapierre JM, Gosset P, LeLorc'h M, Raoul O,Turleau C, Vekemans M, Romana SP. Molecular characterization of partial trisomy16q24.1-qter: clinical report and review of the literature. Am J Med Genet. 2002 Dec 15;113(4):339-45. Review.
3. Ensembl Human Map View: Chromosome 16
4. Gilbert F. Disease genes and chromosomes: disease maps of the human genome.Chromosome 16. Genet Test. 1999;3(2):243-54.
5. Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, anddevelopment. Genes Dev. 2000 Jul 1;14(13):1553-77. Review.
6. Iyer NG, Ozdag H, Caldas C. p300/CBP and cancer. Oncogene. 2004 May24;23(24):4225-31. Review.
7. Kumar RA, KaraMohamed S, Sudi J, Conrad DF, Brune C, Badner JA, Gilliam TC,Nowak NJ, Cook EH Jr, Dobyns WB, Christian SL. Recurrent 16p11.2 microdeletionsin autism. Hum Mol Genet. 2008 Feb 15;17(4):628-38.
8. Langlois S, Yong PJ, Yong SL, Barrett I, Kalousek DK, Miny P, Exeler R, MorrisK, Robinson WP. Postnatal follow-up of prenatally diagnosed trisomy 16 mosaicism.Prenat Diagn. 2006 Jun;26(6):548-58.
9. Martin J, Han C, Gordon LA, Terry A, Prabhakar S, She X, Xie G, Hellsten U,Chan YM, Altherr M, Couronne O, Aerts A, Bajorek E, Black S, Blumer H, Branscomb E, Brown NC, Bruno WJ, Buckingham JM, Callen DF, Campbell CS, Campbell ML,Campbell EW, Caoile C, Challacombe JF, Chasteen LA, Chertkov O, Chi HC,Christensen M, Clark LM, Cohn JD, Denys M, Detter JC, Dickson M,Dimitrijevic-Bussod M, Escobar J, Fawcett JJ, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Goodwin LA, Grady DL, Grigoriev I, Groza M,Hammon N, Hawkins T, Haydu L, Hildebrand CE, Huang W, Israni S, Jett J, JewettPB, Kadner K, Kimball H, Kobayashi A, Krawczyk MC, Leyba T, Longmire JL, Lopez F,Lou Y, Lowry S, Ludeman T, Manohar CF, Mark GA, McMurray KL, Meincke LJ, MorganJ, Moyzis RK, Mundt MO, Munk AC, Nandkeshwar RD, Pitluck S, Pollard M, Predki P, Parson-Quintana B, Ramirez L, Rash S, Retterer J, Ricke DO, Robinson DL,Rodriguez A, Salamov A, Saunders EH, Scott D, Shough T, Stallings RL, Stalvey M, Sutherland RD, Tapia R, Tesmer JG, Thayer N, Thompson LS, Tice H, Torney DC,Tran-Gyamfi M, Tsai M, Ulanovsky LE, Ustaszewska A, Vo N, White PS, Williams AL, Wills PL, Wu JR, Wu K, Yang J, Dejong P, Bruce D, Doggett NA, Deaven L, SchmutzJ, Grimwood J, Richardson P, Rokhsar DS, Eichler EE, Gilna P, Lucas SM, Myers RM,Rubin EM, Pennacchio LA. The sequence and analysis of duplication-rich humanchromosome 16. Nature. 2004 Dec 23;432(7020):988-94.
10. Miller DT, Chung W, Nasir R, Shen Y, Steinman KJ, Wu BL, Hanson E. 16p11.2Recurrent Microdeletion. 2009 Sep 22 [updated 2015 Dec 10]. In: Adam MP, ArdingerHH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Availablefrom http://www.ncbi.nlm.nih.gov/books/NBK11167/
11. Reilly JT. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): aparadigm for understanding leukaemogenesis? Br J Haematol. 2005 Jan;128(1):18-34.Review.
12. Rozman M, Camós M, Colomer D, Villamor N, Esteve J, Costa D, Carrió A,Aymerich M, Aguilar JL, Domingo A, Solé F, Gomis F, Florensa L, Montserrat E,Campo E. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation. Genes ChromosomesCancer. 2004 Jun;40(2):140-5.
13. Rusconi D, Negri G, Colapietro P, Picinelli C, Milani D, Spena S, Magnani C,Silengo MC, Sorasio L, Curtisova V, Cavaliere ML, Prontera P, Stangoni G, FerreroGB, Biamino E, Fischetto R, Piccione M, Gasparini P, Salviati L, Selicorni A,Finelli P, Larizza L, Gervasini C. Characterization of 14 novel deletionsunderlying Rubinstein-Taybi syndrome: an update of the CREBBP deletionrepertoire. Hum Genet. 2015 Jun;134(6):613-26. doi: 10.1007/s00439-015-1542-9.
14. Shigesada K, van de Sluis B, Liu PP. Mechanism of leukemogenesis by theinv(16) chimeric gene CBFB/PEBP2B-MHY11. Oncogene. 2004 May 24;23(24):4297-307.Review.
15. Stankiewicz P, Sen P, Bhatt SS, Storer M, Xia Z, Bejjani BA, Ou Z, WiszniewskaJ, Driscoll DJ, Maisenbacher MK, Bolivar J, Bauer M, Zackai EH, McDonald-McGinnD, Nowaczyk MM, Murray M, Hustead V, Mascotti K, Schultz R, Hallam L, McRae D,Nicholson AG, Newbury R, Durham-O'Donnell J, Knight G, Kini U, Shaikh TH, Martin V, Tyreman M, Simonic I, Willatt L, Paterson J, Mehta S, Rajan D, Fitzgerald T,Gribble S, Prigmore E, Patel A, Shaffer LG, Carter NP, Cheung SW, Langston C,Shaw-Smith C. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and othermalformations. Am J Hum Genet. 2009 Jun;84(6):780-91. doi:10.1016/j.ajhg.2009.05.005.Oct;85(4):537. multiple author names added.
16. UCSC Genome Browser: Statistics
17. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E,Stefansson H, Ferreira MA, Green T, Platt OS, Ruderfer DM, Walsh CA, Altshuler D,Chakravarti A, Tanzi RE, Stefansson K, Santangelo SL, Gusella JF, Sklar P, Wu BL,Daly MJ; Autism Consortium. Association between microdeletion andmicroduplication at 16p11.2 and autism. N Engl J Med. 2008 Feb 14;358(7):667-75. doi: 10.1056/NEJMoa075974.
18. Yong PJ, Barrett IJ, Kalousek DK, Robinson WP. Clinical aspects, prenataldiagnosis, and pathogenesis of trisomy 16 mosaicism. J Med Genet. 2003Mar;40(3):175-82.